t(16;16)

1 clinical trials · Condition

Record	Firm	Date
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT00801489)	M.D. Anderson Cancer Center	2007-04-04

Every clearance here is in the API, with alerts when new ones post.